Ju­ry says As­traZeneca should pay Pfiz­er $107M+ over Tagris­so in­fringe­ment

A fed­er­al ju­ry in Delaware de­ter­mined that As­traZeneca in­fringed two Pfiz­er patents with its block­buster can­cer treat­ment Tagris­so, and that the British drug­mak­er should pay …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER